Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

106.02
Delayed Data
As of Mar 28
 -0.59 / -0.55%
Today’s Change
87.50
Today|||52-Week Range
139.79
+4.34%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close106.61
Today’s open106.22
Day’s range104.72 - 106.97
Volume226,030
Average volume (3 months)302,371
Market cap$2.2B
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+48.26%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+51.53%
P/E ratioNM
Price/Sales19.42
Price/Book6.53

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.11+0.28%
ENDPEndo International P...+0.24+2.29%
HCMHutchison China Medi...-0.07-0.36%
AGIOAgios Pharmaceutical...-0.44-0.78%
Data as of 03/28/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.79
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs